News Releases | Anagram Therapeutics

News

Check back in for all the latest news from Anagram Therapeutics.

Find recent and archived press releases for Anagram Therapeutics. Explore the latest news and stay up to date on Anagram.

Anagram Therapeutics Presents Positive Data from Clinical Study in People with Cystic Fibrosis (CF) Related Exocrine Pancreatic Insufficiency at North American CF Conference
SEPTEMBER 27, 2024
Anagram Therapeutics Completes Dosing Study of ANG003, a Broad-Spectrum Oral Enzyme Replacement Therapy, in People with Cystic Fibrosis
JULY 30, 2024
Anagram Therapeutics Announces Initiation of Clinical Study of ANG003 in People with Cystic Fibrosis
SEPTEMBER 27, 2023
Anagram Therapeutics Appoints Three Industry Veterans to Leadership Team, Focused on Accelerating the Company’s Pipeline of Orally Delivered Enzymes for Rare Diseases
APRIL 20, 2023
Anagram Therapeutics Launches to Advance Orally Delivered Enzymes to Treat Malabsorption Syndromes and Nutrient Metabolism Disorders
APRIL 4, 2023